ACS Biomarker

Maastricht, Netherlands Founded: 2007 • Age: 19 yrs
Novel biomarkers for cardiac disease are discovered, validated, and commercialized.
Request Access

About ACS Biomarker

ACS Biomarker is a company based in Maastricht (Netherlands) founded in 2007.. ACS Biomarker operates in a competitive market with competitors including BioImage, Lodestone Biomedical, BioAmp Diagnostics, HAWK Biosystems and Araceli Biosciences, among others.

  • Headquarter Maastricht, Netherlands
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ACS Biomarker

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2013 Amount Grant - ACS Biomarker Valuation

investors

May, 2011 Amount Series A - ACS Biomarker Valuation Life Sciences Fund Amsterdam , Brightlands Venture Partners
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ACS Biomarker

ACS Biomarker has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Life Sciences Fund Amsterdam and Brightlands Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Brightlands Venture Partners is focused on venture capital investments.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ACS Biomarker

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ACS Biomarker

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Acs Biomarker Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ACS Biomarker

ACS Biomarker operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioImage, Lodestone Biomedical, BioAmp Diagnostics, HAWK Biosystems and Araceli Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Bioassays are developed for biopharmaceutical firms and research organizations.
domain founded_year HQ Location
Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology
domain founded_year HQ Location
Developers of diagnostic tests that help to treat patient with a specific antibiotic
domain founded_year HQ Location
Clinical assays are developed for quantifying novel biomarkers in samples.
domain founded_year HQ Location
Scientific tools for tissue and cell-based biomarker discovery are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Acs Biomarker

Frequently Asked Questions about ACS Biomarker

When was ACS Biomarker founded?

ACS Biomarker was founded in 2007 and raised its 1st funding round 4 years after it was founded.

Where is ACS Biomarker located?

ACS Biomarker is headquartered in Maastricht, Netherlands. It is registered at Maastricht, Limburg, Netherlands.

Who is the current CEO of ACS Biomarker?

Heico Breek is the current CEO of ACS Biomarker.

What does ACS Biomarker do?

Founded in 2007, ACS Biomarker operates as a biotechnology firm in Maastricht, Netherlands, where biomarkers for cardiac disease are developed to enhance prognosis and management. Discovery and validation processes are emphasized to identify molecular mechanisms underlying disorders, supporting early detection and reducing healthcare costs. Additionally, biomarkers are utilized in drug development to evaluate therapeutic efficacy and safety at initial stages.

Who are the top competitors of ACS Biomarker?

ACS Biomarker's top competitors include Araceli Biosciences, Lodestone Biomedical and BioAmp Diagnostics.

Who are ACS Biomarker's investors?

ACS Biomarker has 3 investors. Key investors include European Union, Life Sciences Fund Amsterdam, and Brightlands Venture Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available